Catherine Moukheibir Moon Lake Immunotherapeutics (MLTX) insider trading activity

Catherine Moukheibir is Director of MoonLake Immunotherapeutics. Currently has a direct ownership of 0 shares of MLTX, which is worth approximately $0. The most recent transaction as insider was on Jul 03, 2025, when has been sold 23,500 shares (Class A ordinary shares, par value $0.0001 per share) at a price of $48.79 per share, resulting in proceeds of $1,146,565. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

n/a 3M change

n/a 12M change

Total Value Held $0

Catherine Moukheibir Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jul 03 2025	SELL Open market or private sale	$1,146,565 $48.79 p/Share	23,500 Reduced 100.0%	0 Class A ordinary share...
Jul 03 2025	BUY Exercise of conversion of derivative security	-	23,500 Added 50.0%	23,500 Class A ordinary share...

Also insider at

IRWD

IRONWOOD PHARMACEUTICALS INC Healthcare